Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Deferred Revenue: 2020-2024

Historic Current Deferred Revenue for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $262.2 million.

  • Cellebrite DI's Current Deferred Revenue rose 7.99% to $262.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $262.2 million, marking a year-over-year increase of 7.99%. This contributed to the annual value of $262.2 million for FY2024, which is 7.99% up from last year.
  • According to the latest figures from FY2024, Cellebrite DI's Current Deferred Revenue is $262.2 million, which was up 7.99% from $242.8 million recorded in FY2023.
  • Over the past 5 years, Cellebrite DI's Current Deferred Revenue peaked at $262.2 million during FY2024, and registered a low of $139.0 million during FY2020.
  • Its 3-year average for Current Deferred Revenue is $233.3 million, with a median of $242.8 million in 2023.
  • Data for Cellebrite DI's Current Deferred Revenue shows a peak YoY rose of 24.60% (in 2023) over the last 5 years.
  • Cellebrite DI's Current Deferred Revenue (Yearly) stood at $139.0 million in 2020, then grew by 14.70% to $159.4 million in 2021, then climbed by 22.25% to $194.9 million in 2022, then grew by 24.60% to $242.8 million in 2023, then increased by 7.99% to $262.2 million in 2024.